RESEARCH WE FUND
ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)
Advanced lung disease doesn’t go on hold once a patient is placed on a lung transplant waiting list. Often, the respiratory condition of the patient continues to deteriorate. ECMO (Extracorporeal membrane oxygenation) can be a temporary lifesaver, providing lungs with out-of-body mechanical support during periods of acute respiratory failure.
Here’s how ECMO works: Blood is drawn from the body. The EMO machine delivers oxygen to the blood and removes carbon dioxide from it, then returns the blood to the body thereby sustaining life.
Join us in making ECMO available to everyone who needs it. Donate today.
EVLP (EX VIVO LUNG PERFUSION)
Patients suffering from advanced-stage lung disease —for whom a lung transplant could prolong life — face a couple of hard truths. One is that there is a shortage of donor lungs. The second is the fact that 85% of available lungs are discarded due to infection, damage and inflammation. EVLP is a medical advancement designed to expand the available pool of lungs by allowing them to be reconditioned for transplant outside the donor body.
Let’s not rest till everyone in need of a new lung gets one. Donate now.
If researchers at the Columbia Center for Translational Immunology (CCTI) have their way, the complicated, lifelong regimen of immune-suppressing drugs that lung transplant patients are currently prescribed may soon be a thing of the past.
Right now, they are pursuing a transplant tolerance technique that ‘tricks’ the body into thinking a donated organ is its own —without the use of an immunosuppressants. Once perfected, this technique may finally make immunosuppressants, the leading cause of infection and organ rejection a thing of the past.
Help make their research a reality. Donate generously.
With the shortage of healthy donor lungs available and thousands of patients in need of them, researchers at CUMU are working to perfect a life-saving alternative, xenotransplantation, the use of animal organs for human transplantation.
Fact is, Xenotransplantation could create an unlimited source of transplantable lungs and help to end transplant waiting lists, and the patient deaths associated with them. But there are challenges, not the least of which is the cost of moving this promising advance forward. Please help to fund this life-saving research.